Fact CheckerSign in

NCT06891534Recruiting

Circadian Rhythms in Human Adipose

Circadian Regulation of Human Adipose Tissue Metabolism

Source: ClinicalTrials.gov · Last updated 14 Apr 2026

Brief summary (registry, in English)

The goal of this study is to understand the underlying circadian rhythms in subcutaneous adipose tissue of humans with our without continuous feeding and how these are altered in people who have obesity.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
17 Mar 2025
Start date
1 Jul 2021
Primary completion date
Dec 2029
Lead sponsor
Mayo Clinic
Diseases
Obesity
NCT number
NCT06891534

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Jul 2021 to the primary completion date, Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • sleep medication use

Other illness

  • History of mediations that impact adipocyte/lipid metabolism
  • Allergy to lidocaine

Other

  • smoking
  • insomnia
  • sleep apnea
  • employment in night or shift work
  • extreme chronotypes

Who the study is looking for

  • BMI 20-25 kg/m2 or 30-37 kg/m2
  • For participants with obesity a waist-to-hip ratio of ≥0.95 in males and ≥0.90 in females.
  • sedentary
  • females: non pregnant or breastfeeding
  • ability to provide written informed consent and follow study instructions

Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic
Coordinator of this site? Confirm its status
RochesterUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.